Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma

NCT04824352 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

44

Enrollment

OTHER

Sponsor class

Stopped Because we then tried another trial with radomised design.

Conditions

Effect of Drug
Toxicity, Drug

Interventions

DRUG: apatinib

Sponsor

Peking University People's Hospital

Collaborators

[object Object]